REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 28 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $119,000 | -38.7% | 232,614 | +11.7% | 0.00% | – |
Q4 2018 | $194,000 | -43.6% | 208,178 | +7.9% | 0.00% | – |
Q3 2018 | $344,000 | +29.3% | 192,902 | +2.1% | 0.00% | – |
Q2 2018 | $266,000 | -0.7% | 188,961 | +6.5% | 0.00% | – |
Q1 2018 | $268,000 | -24.7% | 177,408 | +0.5% | 0.00% | – |
Q4 2017 | $356,000 | -14.6% | 176,561 | +2.5% | 0.00% | – |
Q3 2017 | $417,000 | -12.2% | 172,217 | +3.5% | 0.00% | – |
Q2 2017 | $475,000 | – | 166,428 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 169,901 | $411,000 | 0.03% |
Benin Management CORP | 14,300 | $35,000 | 0.01% |
Northeast Financial Consultants Inc | 15,000 | $36,000 | 0.01% |
WEDBUSH SECURITIES INC | 25,500 | $62,000 | 0.01% |
Zurcher Kantonalbank (Zurich Cantonalbank) | 49,167 | $119,000 | 0.00% |
Renaissance Technologies | 344,299 | $833,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 8,238 | $20,000 | 0.00% |
NORTHERN TRUST CORP | 47,859 | $116,000 | 0.00% |
GROUP ONE TRADING, L.P. | 28 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 146,083 | $353,000 | 0.00% |